Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
SG&A Expenses
$19.35M
TTM · Period ending: · USD
LCTX SG&A Expenses
Latest reported$19.35Mperiod ending
Latest reported$19.35Mperiod ending
LCTX TTM SG&A Expenses ($700.00K → $19.35M)
TTM SG&A Expenses
High-resolution chart · PNG
LCTX sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 19,345,000 | |
| 18,687,000 | |
| 18,460,000 | |
| 18,009,000 | |
| 18,228,000 | |
| 18,031,000 | |
| 18,018,000 | |
| 17,762,000 | |
| 17,393,000 | |
| 17,279,000 | |
| 17,159,000 | |
| 17,362,000 | |
| 17,743,000 | |
| 18,764,000 | |
| 22,509,000 | |
| 22,585,000 | |
| 23,480,000 | |
| 22,746,000 | |
| 18,212,000 | |
| 17,304,000 | |
| 15,615,000 | |
| 14,987,000 | |
| 15,571,000 | |
| 16,559,000 | |
| 17,540,000 | |
| 19,890,000 | |
| 24,031,000 | |
| 26,560,000 | |
| 28,373,000 | |
| 27,342,000 | |
| 24,726,000 | |
| 23,504,000 | |
| 21,669,000 | |
| 20,865,000 | |
| 19,922,000 | |
| 19,454,000 | |
| 19,441,000 | |
| 21,654,000 | |
| 28,425,000 | |
| 33,305,000 | |
| 36,276,000 | |
| 35,826,000 | |
| 29,132,800 | |
| 23,701,698 | |
| 20,418,148 | |
| 19,068,120 | |
| 17,556,491 | |
| 17,049,319 | |
| 17,055,744 | |
| 15,841,342 | |
| 15,590,316 | |
| 14,632,828 | |
| 12,599,858 | |
| 11,391,929 | |
| 10,344,489 | |
| 9,981,363 | |
| 9,676,169 | |
| 9,713,789 | |
| 9,339,931 | |
| 8,054,853 | |
| 7,589,773 | |
| 6,705,187 | |
| 5,643,638 | |
| 1,920,734 | |
| 3,093,236 | |
| 2,426,707 | |
| 2,175,583 | |
| 5,079,149 | |
| 3,234,322 | |
| 2,866,534 | |
| 2,620,299 | |
| 2,133,356 | |
| 1,557,493 | |
| 1,318,907 | |
| 1,300,748 | |
| 1,280,312 | |
| 1,365,793 | |
| 1,474,400 | |
| 1,493,501 | |
| 1,505,191 | |
| 1,446,255 | |
| 1,378,814 | |
| 1,395,933 | |
| 1,460,860 | |
| 1,498,584 | |
| 1,529,980 | |
| 1,484,372 | |
| 1,372,383 | |
| 1,319,103 | |
| 1,331,336 | |
| 1,260,712 | |
| 1,488,446 | |
| 1,412,460 | |
| 1,324,520 | |
| 1,318,159 | |
| 955,221 | |
| 1,537,799 | |
| 1,860,662 | |
| 1,966,252 | |
| 2,201,607 |